Board of Directors

Daniel G. Welch (Chairman)
Biotechnology Executive

Emil D. Kakkis M.D., Ph.D.
Chief Executive Officer, Ultragenyx Pharmaceutical Inc.

William Aliski
Biotechnology Executive

Deborah Dunsire, M.D.
President and Chief Executive Officer, Lundbeck

Lars Ekman, M.D., Ph.D
Executive Partner, Sofinnova Ventures

Matthew K. Fust
Former Executive Vice President and Chief Financial Officer, Onyx Pharmaceuticals, Inc.

Michael Narachi
President and Chief Executive Officer, CODA Biotherapeutics, Inc.

Clay B. Siegall, Ph.D.
Chairman and Chief Executive Officer, Seattle Genetics, Inc.